Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Conditions
Recurrent Glioblastoma, IDH-Wildtype · Recurrent MGMT-Methylated Glioblastoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
Contact: Principal Investigator (Alyx B. Porter Umphrey)City of Hope Comprehensive Cancer Center, Duarte, California, United States
Contact: Principal Investigator (Jana L. Portnow)UC San Diego Moores Cancer Center, La Jolla, California, United States
Contact: Principal Investigator (David E. Piccioni)Keck Medicine of USC Koreatown, Los Angeles, California, United States
Los Angeles General Medical Center, Los Angeles, California, United States
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
Contact: Principal Investigator (Orwa Aboud)UCHealth University of Colorado Hospital, Aurora, Colorado, United States
Contact: Principal Investigator (Denise M. Damek)UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States
Contact: Principal Investigator (Macarena I. De La Fuente)UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States
Contact: Principal Investigator (Macarena I. De La Fuente)Mayo Clinic in Florida, Jacksonville, Florida, United States
Contact: Principal Investigator (Sani H. Kizilbash)University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
Contact: Principal Investigator (Macarena I. De La Fuente)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Patrick T. Grogan)Emory University Hospital Midtown, Atlanta, Georgia, United States
Contact: Principal Investigator (Kimberly Hoang)Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Kimberly Hoang)University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222Contact: Principal Investigator (Steven J. Chmura)University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222Contact: Principal Investigator (Steven J. Chmura)University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States
Contact: Principal Investigator (John L. Villano)Mayo Clinic in Rochester, Rochester, Minnesota, United States
Contact: Principal Investigator (Sani H. Kizilbash)Saint Barnabas Medical Center, Livingston, New Jersey, United States
Contact: Principal Investigator (Vincent Yeung)Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Contact: Principal Investigator (Vincent Yeung)Rutgers New Jersey Medical School, Newark, New Jersey, United States
Contact: Principal Investigator (Vincent Yeung)Roswell Park Cancer Institute, Buffalo, New York, United States
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States
Contact: Principal Investigator (Jose R. McFaline Figueroa)NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Roy E. Strowd)University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Lalanthica V. Yogendran)Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (Pierre Giglio)University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States
Contact: Principal Investigator (Lalanthica V. Yogendran)University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (James D. Battiste)University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Megan Mantica)Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
University of Virginia Cancer Center, Charlottesville, Virginia, United States
VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States
Contact: Principal Investigator (Mariza Daras)University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States
Contact: Principal Investigator (Ankush Bhatia)University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States
Contact: Principal Investigator (Ankush Bhatia)
Study leads
Frances E Chow
Principal Investigator
City of Hope Comprehensive Cancer Center LAO